United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

otsuka pharmaceuticals (u.k. - aripiprazole - powder and solvent for suspension for injection - 400mg

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - droperidol, quantity: 2.5 mg/ml - injection, solution - excipient ingredients: tartaric acid; mannitol; water for injections - in anaesthesia - drolepton is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droleptan is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain. in psychiatry - the management of severe agitation, hyperactivity, or agressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

Israel - English - Ministry of Health

lundbeck israel ltd. - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 300 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

Israel - English - Ministry of Health

lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 300 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

Israel - English - Ministry of Health

lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 300 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

Israel - English - Ministry of Health

lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 300 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

Israel - English - Ministry of Health

lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 400 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

Israel - English - Ministry of Health

lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 400 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

Israel - English - Ministry of Health

lundbeck israel ltd. - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 400 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

Israel - English - Ministry of Health

lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 400 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.